Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YYD302 vs Synovian in Knee Osteoarthritis
NCT03561779Phase 3Completed
- Sponsor
- Yooyoung Pharmaceutical
- Start
- Feb 2018
- Primary completion
- Jun 2019
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of YYD302 in osteoarthritis (OA), sponsored by Yooyoung Pharmaceutical. Started Feb 2018; status: completed.
02
Drugs
YYD302
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03561779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03561779.